The global urology laser market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.27 billion in 2026 to USD 2.03 billion by 2034, registering a CAGR of 6% during the forecast period from 2026 to 2034. North America dominated the urology laser market with a market share of 38.5% in 2025.
Urology lasers are medical laser systems used to diagnose and treat conditions affecting the urinary tract and male reproductive system. They are commonly used for kidney stone removal, prostate procedures, tumor treatment, and other minimally invasive surgeries. These systems offer precise tissue treatment with reduced bleeding and faster recovery. Demand is growing due to rising urological disorders, an aging population, and advances in laser-based surgical techniques.
Download a Free Sample To learn more about this report,
Increasing Adoption of Thulium Fiber Lasers for Stone Treatment
The urology laser market is shifting beyond conventional holmium:YAG systems toward thulium fiber laser (TFL) technology for endoscopic stone treatment. TFL provides urologists with another laser platform for fragmentation and dusting during flexible ureteroscopy, while current clinical guidance recognizes both Ho:YAG and TFL as effective laser systems for flexible ureteroscopy. This is increasing the importance of laser platforms that can provide efficient stone disintegration while supporting different procedural techniques.
Expansion of Laser Applications From Lithotripsy to Prostate Procedures
The urology laser market is increasingly characterized by applications across both urinary stone management and benign prostatic obstruction. Laser platforms are being used for lithotripsy, prostate vaporization, and anatomical enucleation, allowing healthcare facilities to deploy laser technology across multiple urological procedures. This broader application base is increasing the value of versatile systems, compatible fibers, and technologies that can support different surgical techniques.
Increasing Use of Endoscopic Laser Lithotripsy Supports Urology Laser Demand
The continued use of ureteroscopy for urinary stone treatment is increasing demand for intracorporeal laser systems. Flexible ureteroscopy requires effective stone fragmentation and dusting within the urinary tract, making laser energy an important component of modern endourological procedures. As clinicians use ureteroscopic approaches across different stone locations and sizes, demand for reliable laser generators and compatible delivery fibers is supported.
High Equipment and Training Requirements Can Limit Laser Adoption
Urology laser systems require specialized capital equipment, compatible laser fibers, safety infrastructure, and trained clinicians. The technical learning curve can also affect procedural performance, particularly for advanced techniques such as HoLEP and ThuLEP. These equipment, training, and operational requirements can make adoption more difficult for smaller hospitals and facilities with limited urological procedure volumes.
Growth of Laser Enucleation Creates Opportunities for Multi-Application Systems
The increasing use of laser enucleation for benign prostatic obstruction creates opportunities for manufacturers to supply systems that can support both prostate surgery and stone treatment. HoLEP and ThuLEP provide size-independent surgical options, while thulium-based technologies can also be used for vaporization and vapoenucleation. Platforms capable of supporting multiple procedures can therefore improve equipment utilization and broaden their addressable hospital customer base.
Managing Laser Energy, Irrigation, and Tissue Temperature Complicates Procedure Optimization
Higher laser power can improve stone fragmentation efficiency and reduce procedural time, but laser energy also introduces thermal and pressure-management considerations during endoscopic procedures. Adequate irrigation, outflow, access-sheath design, and appropriate laser settings must be coordinated to maintain visualization while limiting temperature and intrarenal pressure increases. This makes system design and procedural technique important factors in safe and consistent laser use.
Holmium Laser System Segment Dominated the Market with 43.6% Share in 2025
The holmium laser system segment dominated the global urology laser market with a 43.6% share in 2025. Holmium lasers are widely used in urological procedures because of their effectiveness in stone fragmentation and treatment of enlarged prostate tissue. Their versatility across different minimally invasive procedures and established clinical use continue to strengthen the segment's leading position.
Thulium laser systems accounted for 25.4% and are growing at the highest CAGR of 8.2%, supported by their precise tissue cutting, controlled penetration, and increasing use in prostate procedures. Diode laser systems also remain important for various soft-tissue applications. Technological improvements in minimally invasive procedures are supporting urology laser market growth across different laser types.
Request Customizationto receive a tailored report.
Benign Prostatic Hyperplasia Segment Dominated the Market with 39.7% Share in 2025
The benign prostatic hyperplasia segment dominated the global urology laser market with a 39.7% share in 2025. Laser procedures are increasingly used to remove or reduce excess prostate tissue and improve urinary symptoms associated with an enlarged prostate. Growing preference for minimally invasive procedures with reduced bleeding and shorter recovery periods continues to support this segment.
Urolithiasis accounted for 36.5% of the market, driven by the extensive use of lasers for fragmenting kidney and urinary tract stones. Non-muscle-invasive bladder cancer is growing at a CAGR of 7.1%, supported by increasing adoption of advanced laser techniques in selected procedures.
Other applications contribute through specialized urological treatments. Increasing adoption of laser-based procedures is supporting urology laser market demand across different applications.
Hospitals & Clinics Segment Dominated the Market with 58.4% Share in 2025
The hospitals & clinics segment dominated the global urology laser market with a 58.4% share in 2025. These healthcare facilities perform a large number of urological procedures and have access to specialized surgeons, advanced laser systems, diagnostic equipment, and supporting infrastructure. Their ability to manage both routine and complex procedures continues to strengthen the segment's leading position.
Ambulatory surgical centres accounted for 25.3% and are growing at the highest CAGR of 8.1%. Increasing preference for outpatient procedures, shorter hospital stays, and minimally invasive treatments is supporting their expansion.
Dialysis centers and other healthcare facilities also contribute to demand for specialized urological treatments. The continued shift toward efficient outpatient care is expected to increase the adoption of laser-based procedures across different healthcare settings.
Speak to an Analystto discuss market opportunities.
North America urology laser market accounted for 38.5% of the global market, reaching USD 0.46 billion in 2025, and is projected to grow at a CAGR of 6.4% during the forecast period. The region benefits from advanced healthcare infrastructure, widespread adoption of minimally invasive urological procedures, and increasing treatment of kidney stones and benign prostatic hyperplasia. Hospitals and specialty clinics are also adopting advanced holmium and thulium laser systems to improve surgical precision and patient recovery.
The US market was valued at USD 0.39 billion in 2025, making it the largest contributor in North America. High adoption of minimally invasive urological procedures, advanced hospital infrastructure, and increasing use of laser systems for kidney stone and prostate treatments continue to support market growth.
Canada's market reached USD 0.07 billion in 2025. Growing adoption of minimally invasive treatments, improvements in urological care, and increasing availability of advanced laser technologies are supporting market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe urology laser market accounted for 28.2% of the global market, reaching USD 0.34 billion in 2025, and is expected to register a CAGR of 6.1% during the forecast period. An aging population, increasing prevalence of urological disorders, and growing preference for minimally invasive procedures are supporting regional demand. Hospitals are increasingly investing in advanced laser technologies that can reduce bleeding, shorten hospital stays, and improve treatment outcomes.
Germany's market accounted for USD 0.10 billion in 2025. Advanced healthcare infrastructure, strong adoption of minimally invasive surgery, and increasing availability of modern urology laser systems continue to support market growth.
The UK market was valued at USD 0.07 billion in 2025. Increasing treatment of kidney stones and prostate conditions, growing adoption of laser-based procedures, and improvements in urological healthcare services continue to contribute to market development.
Asia Pacific urology laser market accounted for 23.4% of the global market, valued at USD 0.28 billion in 2025, and is projected to register the fastest regional CAGR of 8.3% during the forecast period. Increasing healthcare expenditure, expansion of hospital infrastructure, and growing awareness of minimally invasive urological treatments are driving regional demand. Rising cases of kidney stones and prostate disorders are also increasing the need for advanced laser-based treatment systems.
Japan's market generated USD 0.05 billion in 2025. An aging population, advanced healthcare infrastructure, and strong adoption of minimally invasive medical technologies continue to support demand for urology laser systems.
China's market accounted for USD 0.15 billion in 2025, making it a major contributor within Asia Pacific. Expansion of hospital infrastructure, increasing healthcare expenditure, and growing adoption of advanced laser procedures for kidney stones and prostate disorders continue to drive market growth.
Middle East & Africa urology laser market accounted for 4.2% of the global market, reaching USD 0.05 billion in 2025, and is anticipated to grow at a CAGR of 6.6% during the forecast period. Investment in modern healthcare facilities, increasing access to specialized urological care, and growing adoption of minimally invasive procedures are supporting regional market development.
The UAE market was valued at USD 0.02 billion in 2025. Advanced hospital infrastructure, increasing investment in specialized medical technologies, and growing availability of minimally invasive urological procedures continue to support market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Cochlear Implants Market Size, Share, Growth, Forecast, 2034
Fluoroscopy Equipment Market Size, Share, Growth, Analysis, 2034
Endoscopes Market Size, Share, Growth, Analysis, Report, 2034
Acute Wound Care Market Size, Share, Growth, Forecast, 2034
Digital Therapeutics Market Size, Share, Growth, Analysis, 2034
Breast Reconstruction Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com